Real world evidence: a comparison of the Australian Herceptin Program and clinical trials of trastuzumab for HER2+ metastatic breast cancer

Publisher:
Adis
Publication Type:
Journal Article
Citation:
PharmacoEconomics, 2016, 34 (10), pp. 1039 - 1050
Issue Date:
2016
Full metadata record
Files in This Item:
Filename Description Size
rv_mh_sg_pharmacoeconomics.pdfPublished Version493.21 kB
Adobe PDF
Please use this identifier to cite or link to this item: